11 Apex Drive Suite 300 A
PMB 2006
Marlborough, MA
United States 01753
Phio Pharmaceuticals is a clinical-stage biopharmaceutical company advancing its proprietary INTASYL siRNA gene silencing technology focused on immuno-oncology therapeutics. Phio's INTASYL compounds are designed to enhance our body's immune cells to more effectively kill cancer cells.